A Study to Evaluate Sapablursen (Formerly ISIS 702843, IONIS-TMPRSS6-LRx) in Patients With Polycythemia Vera
Trial details
- Registry ID
- NCT05143957
- Phase
- Phase 2
Drug identity checked against registry records
Also recorded as IONIS TMPRSS6-LRx; IONIS-TMPRSS6-LRx; ISIS 702843
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| A Study to Evaluate Sapablursen (Formerly ISIS 702843, IONIS-TMPRSS6-LRx) in Patients With Polycythemia VeraNCT05143957 | IONS | Phase 2 | Completed | 2025-06-26Actual |
| Study to Evaluate the Efficacy, Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Sapablursen (Formerly ISIS 702843, IONIS-TMPRSS6-LRx)NCT04059406 | IONS | Phase 2 | Terminated | 2023-03-28Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |